Cannabidiol Market Summary

The global cannabidiol market size was estimated at USD 9.14 billion in 2024 and is projected to reach USD 22.05 billion by 2030, growing at a CAGR of 15.8 percent from 2025 to 2030. The CBD market size is expected to expand significantly as more countries and regions legalize hemp based products, creating a favorable regulatory environment and encouraging investment in product development and distribution.

Companies are developing a wide range of cannabidiol products, including edibles, topicals, oils, tinctures, and beverages, to cater to the increasing consumer demand for natural wellness solutions. The expansion of e commerce platforms has further accelerated market growth by enabling businesses to reach broader global audiences, streamline direct sales, and promote product awareness. Online retail channels have become a key driver of market penetration, especially in regions with limited access to physical stores.

Key Market Trends & Insights

• In 2024, North America dominated the market with a revenue share of 86.7 percent. This dominance is supported by early legalization trends, high consumer awareness, and the presence of major CBD product manufacturers and distributors.
• Europe is expected to witness the fastest growth over the forecast period due to evolving regulatory reforms, rising interest in plant based health supplements, and expanding consumer acceptance of CBD infused products.
• Based on source type, the hemp segment dominated the market and generated 56.8 percent of the revenue in 2024. This is largely because hemp contains low levels of THC and is legally approved in many countries for commercial CBD extraction.
• Based on sales type, the B2B segment dominated the market and accounted for the largest revenue share in 2024. Businesses are increasingly sourcing CBD ingredients and bulk products for use in pharmaceuticals, cosmetics, nutraceuticals, and food and beverage applications.
• Based on end use, the pharmaceuticals segment accounted for the largest revenue share in 2024. This segment benefits from the growing adoption of CBD in pain management, anxiety relief, epilepsy treatment, and other therapeutic applications.

Order a free sample PDF of the Cannabidiol Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 9.14 Billion
• 2030 Projected Market Size: USD 22.05 Billion
• CAGR (2025-2030): 15.8%
• North America: Largest market in 2024
• Europe: Fastest growing market

Key Companies & Market Share Insights

Some of the key players operating in the market include ENDOCA, Cannoid, LLC, Medical Marijuana, Inc., Canopy Growth Corporation and Folium Europe B.V

• ENDOCA primarily manufactures and distributes pharmaceutical-grade hemp-derived cannabidiol (CBD) products across the globe. The vertically integrated company is involved in cultivating, processing, extracting, and selling CBD products.
• Cannoid, LLC produces hemp-based therapeutics and works on a contract basis. The company’s primary focus is on cannabinoid oil encapsulation. It offers softgels for various purposes. Its product portfolio includes soft gels with Cannabidivarin (CBDV) for neuromodulation, soft gels with controlled Cannabidiolic Acid (CBDA), and Cannabigerolic Acid (CBGA) fractions intended for immunity.

NuLeaf Naturals, LLC, Isodiol International Inc., PharmaHemp, and The Cronos Group Cannoid, LLC, are some of the emerging market participants in the cannabidiol market.

• NuLeaf Naturals, LLC manufactures and distributes hemp-derived CBD products in the U.S. market. The company provides wholesale, lab-tested, and organic CBD oil & extracts to its consumers in the global market.
• PharmaHemp produces and supplies a range of Cannabidiol (CBD) products. The company provides a range of CBD products under its brand “PharmaHemp CBD.”

Key Players

• ENDOCA
• Cannoid, LLC
• Medical Marijuana, Inc.
• Folium Europe B.V.
• Canopy Growth Corporation
• Elixinol
• NuLeaf Naturals, LLC
• Isodiol International, Inc.
• PharmaHemp
• The Cronos Group

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The cannabidiol market is poised for strong growth as global legalization efforts expand and consumer interest in natural wellness solutions increases. The surge in product innovation, rising acceptance of hemp derived ingredients, and rapid enlargement of online retail channels continue to strengthen the market outlook. With North America leading in revenue share and Europe emerging as the fastest growing region, opportunities for market expansion remain substantial. The dominance of hemp based sourcing, the strength of the B2B channel, and increasing pharmaceutical applications collectively contribute to sustained industry momentum, positioning CBD as an influential component of the evolving global health and wellness landscape.